← Open Payments lookup

KRISTA BLAYLOCK: Open Payments

NPI 1609178094 · KOSCIUSKO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 39 payments from 11 companies in 2025. Trend: 2023 $1,378 · 2024 $1,766 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$370
Novo Nordisk Inc10$163
Otsuka America Pharmaceutical, Inc.2$60
ABBVIE INC.3$50
GlaxoSmithKline, LLC.3$46
PFIZER INC.2$30
Averitas Pharma Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
CSL Behring1$23
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: FARXIGA, BREZTRI, Ozempic, REXULTI, TRELEGY ELLIPTA, UBRELVY, AIRSUPRA, ELIQUIS.

Industry payments across MS — which companies pay providers there.